A221800 Stock Overview
Provides healthcare services in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
U2Bio Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩2,515.00 |
| 52 Week High | ₩6,050.00 |
| 52 Week Low | ₩2,370.00 |
| Beta | 0 |
| 1 Month Change | -9.53% |
| 3 Month Change | -17.27% |
| 1 Year Change | -52.46% |
| 3 Year Change | -67.50% |
| 5 Year Change | -29.65% |
| Change since IPO | -36.73% |
Recent News & Updates
Recent updates
Shareholder Returns
| A221800 | KR Healthcare | KR Market | |
|---|---|---|---|
| 7D | -6.9% | 0.6% | -1.6% |
| 1Y | -52.5% | -19.0% | -9.1% |
Return vs Industry: A221800 underperformed the KR Healthcare industry which returned -19% over the past year.
Return vs Market: A221800 underperformed the KR Market which returned -9.1% over the past year.
Price Volatility
| A221800 volatility | |
|---|---|
| A221800 Average Weekly Movement | 12.1% |
| Healthcare Industry Average Movement | 9.2% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in KR Market | 12.6% |
| 10% least volatile stocks in KR Market | 3.3% |
Stable Share Price: A221800's share price has been volatile over the past 3 months compared to the KR market.
Volatility Over Time: A221800's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | n/a | Jin-Tae Kim | www.u2bio.co.kr |
U2Bio Co., Ltd. provides healthcare services in South Korea. The company also offers clinical laboratory test services; digital healthcare services related to testing and health examinations; and bio-technology platforms. The company was founded in 2009 and is headquartered in Seoul, South Korea.
U2Bio Co., Ltd. Fundamentals Summary
| A221800 fundamental statistics | |
|---|---|
| Market cap | ₩31.72b |
| Earnings (TTM) | ₩0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs A221800 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A221800 income statement (TTM) | |
|---|---|
| Revenue | ₩0 |
| Cost of Revenue | ₩0 |
| Gross Profit | ₩0 |
| Other Expenses | ₩0 |
| Earnings | ₩0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did A221800 perform over the long term?
See historical performance and comparisonDividends
1.2%
Current Dividend Yieldn/a
Payout RatioDoes A221800 pay a reliable dividends?
See A221800 dividend history and benchmarks| U2Bio dividend dates | |
|---|---|
| Ex Dividend Date | Dec 27 2024 |
| Dividend Pay Date | Apr 14 2025 |
| Days until Ex dividend | 6 days |
| Days until Dividend pay date | 114 days |
Does A221800 pay a reliable dividends?
See A221800 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 12:42 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | N/A |
| Annual Earnings | N/A |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
U2Bio Co., Ltd. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jiwoo Baek | Shinhan Investment Corp. |